drugset / Trial / NCT02587117

A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus

NCT02587117

Phase 4 Completed 28 enrolled B.P. Koirala Institute of Health Sciences
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Oral lichen planus (OLP) is a common sub-acute, chronic inflammatory mucocutaneous disease.This study was evaluated the comparative efficacy of lycopene and prednisolone for the treatment of oral lichen planus. Half of participants (total number of participants was twenty eight) were received lycopene and the other half were received prednisolone.

Timeline

Start
2013-02
Primary completion
2014-01
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lycopene Other / unclassified 4 mg Oral
Comparator Prednisolone Other / unclassified 40 mg Oral

Indications